Skip to main content
SpringerLink
Log in

There appears to be a high prevalence of hypothyroidism, possibly due to an impaired iodine uptake, in patients receiving sunitinib

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Mannavola D, Coco P, Vannucchi G, Bertuelli R, Carletto M, Casali PG, Beck-Peccoz P, Fugazzola L.A novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake. Journal of Clinical Endocrinology and Metabolism 92: 3531-3534, No. 9, Sep 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

There appears to be a high prevalence of hypothyroidism, possibly due to an impaired iodine uptake, in patients receiving sunitinib. React. Wkly. 1176, 3 (2007). https://doi.org/10.2165/00128415-200711760-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200711760-00008

Keywords

Search

Navigation